The largest database of trusted experimental protocols

25 protocols using pd l1

1

Quantification of secreted factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA kits for human TGFβ1, PD-L1 (R&D Systems, UK) and NmU (Peninsula Laboratories, CA) were used according to the manufacturer's instructions. For analysis of conditioned media, HCC1954, SKBR3 and EFM192A cell variants were seeded at 1 × 105 cells/well in a 24-well plate and left to attach overnight. The following day, cells were washed and fed with serum-free media and incubated for a further 72hr. Supernatant was then collected and analyzed immediately or stored at −80°C until analysis. Results were normalized by total cell protein contained in the well. 10µg of protein from lysed or intact EVs, as stated, were tested per well.
+ Open protocol
+ Expand
2

Western Blot Analysis of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in RIPA buffer (50 mM Tris-Cl at pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, 1 μg/mL leupeptin, 1 μg/mL aprotinin, 0.2 mM PMSF). Proteins (20-40 μg) were separated on 8–10% SDS/PAGE gel and then transferred onto PVDF membranes (Millipore, Billerica, MA). After blocking procedure, membranes were incubated with primary antibodies (1:1000), HRP-conjugated secondary antibodies (1:5000), and visualized in Imager (Bio-Rad) using ECL system (Thermo Fisher Scientific, 34095). Antibodies used were; PD-L1 (R&D, MAB1086), p-JAK1 (pY1022, Assay Biotech, A7125), p-JAK2 (pY1007 + 1008, Abbomax, 601-670), p-MAPK (cell Signaling, 9101S), p-Erk (Cell Signaling, 4695), p-MEK (Ser 217/221, Cell Signaling, 9121), p-Akt (S473, Cell Signaling, 9271), and p-Stat3 (pY705, Abcam, ab76315), p-Stat1 (pY701, Abbomax, 620-160), p-Stat5 (Abcam, pY694, ab32364), p-NFκB (S536, Abcam ab86299), p-mTOR (Millipore, 09-345), JAK1 (Abgent, AP20699a), JAK2 (Abgent, AP20700c), Stat1 (Abgent, AP19835b), MEK (Ameritech, ATB-T2715), MAPK (Signalway, 21245), ERK (Ameritech, ATB-T5371), Akt (Santa Cruz, sc5298) and GAPDH (Cell Signaling, 2118S).
+ Open protocol
+ Expand
3

Immunoblotting for PD-L1, PD-L2, and Signaling Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated as described and then lysed in Strawn buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 0.2% Triton × 100 and 10% glycerol) supplemented with a protease inhibitor cocktail (Roche, Mannheim, Germany), sonicated and boiled for 5 min, and separated on SDS-polyacrylamide gels. Consecutively, proteins were immunoblotted on a PVDF membrane. The membrane was blocked in blocking buffer (TBS [pH 7.6], 0.1% Tween-20 and 5% nonfat dry milk) for at least 3 h at 4 °C, followed by incubation with the primary antibody (PD-L1 and PD-L2 both from R&D Systems, Wiesbaden, Germany) in TBS (pH 7.6), 0.05% Tween-20 and 5% BSA. Bound primary antibodies were detected using rabbit anti-goat IgG-horseradish peroxidase conjugates (Dako, Frankfurt, Germany) and visualized with the LumiGlo detection system (CST, Frankfurt, Germany). In the case of PD-L2 a tertiary antibody (anti-rabbit IgG-HRP, CST) was used to enhance the signal strength. Equal loading was controlled by anti-GAPDH or anti-actin (Santa Cruz, Biotechnology, Heidelberg, Germany). In order to detect signaling molecules, the following antibodies were used: p-STAT-1 (Tyr701), STAT-1, p-STAT-2 (Tyr 690), STAT-2, p-STAT-3 (Tyr705), STAT-3, p-JAK-1 (Tyr1022/1023), JAK-1, p-JAK-2 (Tyr1008), JAK-2 and IRF-1, all from CST.
+ Open protocol
+ Expand
4

Cultivation and Antibody Analysis of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cancer cell lines B16F10, DBT, 4 T1, LLC and LM8 were obtained from American Type Culture Collection (Rockville, MD, USA). B16F10, DBT, 4 T1, LLC and LM8 cells were cultured in Dulbecco modified Eagle medium (DMEM)/F12 (Sigma) supplemented with 10% fetal bovine serum and 10 U/ml penicillin and streptomycin (Life Technologies, Grand Island, NY) at 37°C in 5% CO2. Cells were detached using 1 mM EDTA in phosphate-buffered saline solution (PBS) and used for further experiment. Antibodies used for western blotting included PD-L1 (1:1000, R&D Systems, Minneapolis, MN), p-p38 and β-actin (1:1000, Santa Cruz Biotechnology, Dallas, TX). Antibodies for flow cytometry, including pp38, pERK, pJNK pAKT, pmTOR, pp70-S6K, pSTAT1, pSTAT3, pSTAT4 and pSTAT5, were purchased from Cell Signaling Technology.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
After fixing the tissues in 10% formalin followed by paraffin embedding, the FFPE tissue sections were washed with xylene (3 times) and rehydrated with a gradient of ethanol (twice in 100%, 90%, 80%, and 70%). The tissue sections were heated in antigen retrieval buffer (AR9) in a boiling water bath for 12 min for antigen retrieval and then incubated in blocking buffer (5% BSA in PBS with 0.4% Triton-X (PBST)) for 30 min. Slides were incubated in primary antibodies: 1:30 Cep55 (Santa Cruz, Santa Cruz, CA, USA), 1:200 CD8 (Abcam, Cambridge, UK), 1:100 CD4 (Novus Biologicals, Centennial CO, USA), 1:50 FOXP3 (Biotechne), 1:50 TCF1/7 (Cell Signaling, Danvers, MA, USA), Granzyme B (Abcam, Cambridge, UK), 1:100 PD-L1(R&D Systems, Minneapolis, MN, USA), and 1:200 CD3 (Abcam, Cambridge, UK) overnight at 4 °C. The following day, the slides were washed with PBST and incubated in secondary antibodies conjugated with fluorescence for 1 h at room temperature. The slides were washed, mounted with Prolong gold antifade mountant with DAPI, and imaged.
+ Open protocol
+ Expand
6

Comprehensive Antibody Panel for EGFR Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: Flag (F3165; Sigma-Aldrich, St Louis, MO, USA; 1:5,000), Myc (11667203001; Roche Diagnostics, Indianapolis, IN, USA; 1:5,000), HA (11666606001; Roche Diagnostics; 1:5,000), PD-L1 (13684; Cell Signaling Technology, Danvers, MA, USA; 1:1,000), PD-L1 (329702; BioLegend; 1:1,000), PD-L1 (GTX117446; GeneTex, Irvine, CA, USA; 1:1,000), PD-L1 (AF156; R&D Systems, Minneapolis, MN, USA; 1:1,000), PD-1 (ab52587; Abcam, Cambridge, MA, USA; 1:2,000), Granzyme B (ab4059; Abcam; 1:1,000), EGFR (4267; Cell Signaling Technology; 1:1,000), GSK3β (9315; Cell Signaling Technology; 1:1,000), phospho-GSK3β Ser 9 (9336; Cell Signaling Technology; 1:1,000), β-TrCP (4394; Cell Signaling Technology; 1:1,000), α-Tubulin (B-5-1-2; Sigma-Aldrich; 1:5,000), β-Actin (A2228; Sigma-Aldrich; 1:10,000). EGF, cycloheximide and TM were purchased from Sigma-Aldrich. Gefitinib, erlotinib, lapatinib, cetuximab and AG1478 were obtained from Calbiochem Corp (Billerica, MA, USA).
+ Open protocol
+ Expand
7

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in a modified lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 50 mM NaF, 10 mM β-glycerophosphate, 10 nM calyculin A, 1 mM Na3VO4, and protease inhibitors), followed by SDS-PAGE and western blotting analysis as previously described55 (link). The primary antibodies against STAG2 (Santa Cruz, SC-81852), IRF9 (Cell Signaling, #76684), IRF7 (Cell Signaling, #4920), USP18 (Cell Signaling, #4813), ISG15 (Santa Cruz, SC-166755), IRF1 (Cell Signaling, #8478), IRF3 (Cell Signaling, #11904), GAPDH (Cell Signaling, #2118), GAPDH (Cell Signaling, #51332), STAG1 (Novus Biologicals, NB100-298), PD-L1 (R&D Systems, AF156), CTCF (Cell Signaling, #2899), and Flag M2 (Sigma, F3165) were used. All primary antibodies were used at a 1:1,000 dilution, with the exception of GAPDH (1:3000) and PD-L1 (1:200).
+ Open protocol
+ Expand
8

Immunohistochemical Profiling of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was performed on formalin-fixed, paraffin-embedded tissue sections. Serial sections (5-μm thick) were dewaxed and rehydrated. Heat-induced antigen retrieval was followed by endogenous peroxidase activity blockade with hydrogen peroxide. The sections were incubated overnight at 4°C with the following primary antibodies: CD207 (1:50; Atlas Antibodies), VE1 (1:50; Spring Bioscience), FOXP3 (1:75; Abcam), and PDL1 (1:50; R&D Systems). For antigen visualization, a peroxidase-labeled secondary antibody (EnVision/HRP system; DAKO) was used. Subsequently, the sections were rinsed in the kit buffer and immersed in diaminobenzidine stain. The expression of GATA3 (1:100; Cell Signaling Technology) and T-bet (1:50; Abcam) was performed via double IHC staining using DouMaxVision immunohistochemical double dye kits (KIT-9998; Maixin Biotech) according to the manufacturer's instructions, with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium as the blue-black chromogen for alkaline phosphatase and 3-amino-9-ethylcarbazole as the red chromogen for horseradish peroxidase. The sections were counterstained with Harris' hematoxylin and then mounted. For the negative controls, phosphate-buffered saline was used instead of primary antibody.
+ Open protocol
+ Expand
9

Western Blot Analysis of Phospho-STAT3

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T cells were negatively enriched as mentioned above. Cells were lysed in 1% Nonidet P-40 lysis buffer containing protease inhibitor cocktail (Sigma-Aldrich) and 1mMsodium orthovanadate (Sigma-Aldrich). Protein lysates (20 μg) were subjected to SDS-PAGE, probed with indicated antibodies, and detected using an enhanced chemiluminescence substrate (Pierce). Monoclonal β-actin antibody (1:10000) was purchased from Sigma-Aldrich. Polyclonal antibody against p-STAT3 (Y705) (1:1000) was from Cell Signaling. Stattic was purchased from EMD Chemicals and recombinant mouse Leptin and PD-L1 were purchased from R&D Systems.
+ Open protocol
+ Expand
10

Immunomodulatory Evaluation of PD-1 Axis

Check if the same lab product or an alternative is used in the 5 most similar protocols
AML-12 cells (Lot#: HTX2091) and MC38 cells (Lot#: HYC0116) as a kind of mouse hepatocytes and mouse colon cancer cells, respectively, were both bought from Shanghai Bangjing Industrial Co., Ltd (Shanghai, China). Pembrolizumab was bought from Selleck Chemicals LLC (Texas, USA). Human IL-2, IFN-γ ELISA kits, recombinant PD-1, PD-L1 and PD-L2 were purchased from R&D System (Minnesota, USA). C57BL/6 or NOD/SCID mice, human PD-1 (hPD-1) knock-in (C57BL/6 background) mice were bought from Shanghai Model Organisms Science and Technology Co., Ltd. (Shanghai, China). All the animal studies were approved by the Animal Use and Care Committee.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!